A Novel Tool for Multi-Omics Network Integration and Visualization: A Study of Glioma Heterogeneity

Roberta Coletti,João Carrilho,Eduarda P. Martins,Céline S. Gonçalves,Bruno M. Costa,Marta B. Lopes
DOI: https://doi.org/10.1101/2024.03.18.585500
2024-03-20
Abstract:Gliomas are highly heterogeneous tumors with generally poor prognoses. Leveraging multi-omics data and network analysis holds great promise in uncovering crucial signatures and molecular relationships that elucidate glioma heterogeneity. However, the complexity of the problem and the high dimensionality of the data increase the challenges of integrating information across various biological levels. In this study, we developed a framework comprising two steps for variable selection based on sparse network estimation from various omics. Subsequently, we introduced MINGLE (Multi-omics Integrated Network for GraphicaL Exploration), a novel methodology designed to merge distinct multi-omics information into a single network, enabling the identification of underlying relations through an innovative integrated visualization. Applying this method to glioma data, with patients grouped according to the newest glioma classification guidelines, led to the selection of variables as potential candidates for novel glioma-type-specific biomarkers.
Bioinformatics
What problem does this paper attempt to address?
The paper aims to address the issue of glioma heterogeneity. Specifically, it proposes a new method to integrate and visualize multi-omics data to reveal molecular relationships between different types of gliomas. The specific problems the paper attempts to solve are as follows: 1. **Understanding Glioma Heterogeneity**: Glioma is a highly heterogeneous tumor with different molecular characteristics and clinical manifestations. Currently, the understanding of this heterogeneity is still limited, and better methods are needed to uncover key molecular markers. 2. **Integration of Multi-omics Data**: Although modern technology can obtain a large amount of multi-omics data, this data is usually high-dimensional and complex. Effectively integrating this information is a challenge. The paper proposes a new framework to select key variables from different omics layers (such as transcriptomics and methylomics) and integrate them into a single network. 3. **Development of New Methods**: To achieve the above goals, the paper develops a new method called MINGLE (Multi-omics Integrated Network for GraphicaL Exploration). This method performs variable selection through a two-step process and integrates different multi-omics information into a unified network, thereby identifying potential molecular relationships. 4. **Discovery of Potential Biomarkers**: By applying the MINGLE method to glioma data, researchers can identify a set of potential new biomarkers. These markers may help to better understand the molecular mechanisms of different types of gliomas and provide new targets for future therapeutic strategies. In summary, the main goal of this paper is to develop a new multi-omics integration method to reveal the molecular basis of glioma heterogeneity and discover potential biomarkers. This will help improve the understanding of gliomas and support future clinical treatments.